Studies in metachromatic leukodystrophy XI. Therapeutic considerations, 1972.
D000818:Animals; D002552:Cerebral Ventricles; D055598:Chemical Phenomena; D002621:Chemistry; D004195:Disease Models, Animal; D004355:Drug Stability; D006801:Humans; D007267:Injections; D007966:Leukodystrophy, Metachromatic / Q000188:drug therapy* / Q000209:etiology; D009186:Myelin Sheath; D009410:Nerve Degeneration / Q000209:etiology; D010686:Philosophy, Medical; D013346:Subarachnoid Space / Q000378:metabolism; D013429:Sulfatases / Q000008:administration & dosage / Q000134:cerebrospinal fluid / Q000172:deficiency / Q000302:isolation & purification / Q000378:metabolism / Q000627:therapeutic use; D013552:Swine; D014556:Urine / Q000201:enzymology
D013429:Sulfatases